Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Assessing iPSC reprogramming methods for their suitability in translational medicine

Rao MS., Malik N.

Narrative Review, published in J Cell Biochem (2012) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Cell Biochem (2012)
Reported sample size
—
Source database
Europe PMC
PMID
22573568
PMCID
PMC3552293
DOI
10.1002/jcb.24183
Citations
84

Abstract (original English)

The discovery of the ability to induce somatic cells to a pluripotent state through the overexpression of specific transcription factors has the potential to transform the ways in which pharmaceutical agents and cellular transplantation therapies are developed. Proper utilization of the technology to generate induced pluripotent stem cells (iPSCs) requires that researchers select the appropriate reprogramming method for generating iPSCs so that the resulting iPSCs can be transitioned towards clinical applications effectively. This article reviews all of the currently available reprogramming techniques with a focus on critiquing them on the basis of their utility in translational medicine.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
LentivirusMicroRNAsRNA, MessengerReproducibility of ResultsTransfectionRegenerative MedicineCell DifferentiationTransgenesGenetic VectorsPlasmids

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.